Since PSMC6 expression was enhanced in tumor versus normal cells and was found to be associated with progression-free survival, PSMC6 role was further addressed in ovarian cancer cells using a functional approach based on RNA interference in 2D and 3D preclinical models. Here, PSMC6 is linked to ovarian carcinoma.